Skip to content

ICU Medical ICUI Finance Lease, Right-of-Use Asset, after Accumulated Amortization

Finance Lease, Right-of-Use Asset, after Accumulated Amortization at other companies

Solventum logo
SolventumSOLV
ITG
Integer HoldingsITGR

Other financials

Income statement

See full
Revenue$530.2M-12.3%
Gross profit$206.2M-1.8%
Operating income$13.6M+5.4%
Net income$30.1M+295%
EPS (diluted)$1.20+290%

Balance sheet

See full
Cash & equivalents$288.3M-0.5%
Total debt$1.4B-17.5%
Total equity$2.1B+6.3%
Total assets$4.0B-4.1%

Cash flow

See full
Operating cash flow$38.9M-24.2%
CapEx$11.3M-22.7%
Free cash flow$27.6M-24.8%

Valuation

See full
Market cap$3.39B-6.3%

Profitability

See full
Gross margin37.9%+2.8pp
Operating margin2%-0.7pp
Net margin-0.3%-0.2pp
FCF margin4.2%-1.2pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.2×
Current ratio2.3×-0.3×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseRightOfUseAsset.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ICU Medical's finance lease, right-of-use asset, after accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ICU Medical's finance lease, right-of-use asset, after accumulated amortization?
ICU Medical (ICUI) reported finance lease, right-of-use asset, after accumulated amortization of $6.21M in Q1 2026.
How has ICU Medical's finance lease, right-of-use asset, after accumulated amortization changed year-over-year?
ICU Medical's finance lease, right-of-use asset, after accumulated amortization increased by 86.9% year-over-year, from $3.32M to $6.21M.
What is the long-term trend for ICU Medical's finance lease, right-of-use asset, after accumulated amortization?
Over 5 years (2020 to 2025), ICU Medical's finance lease, right-of-use asset, after accumulated amortization has grown at a 13.9% compound annual growth rate (CAGR), from $2.92M to $5.6M.